Brian M. Shuch, MD
Accepting new patients

Brian M. Shuch, MD

  • Minimally Invasive Urology|
  • Urologic Oncology|
  • Urology
Westwood Urology | 200 Medical Plaza, Suite 140, Los Angeles, CA 90095
310-794-7700

About

Brian Shuch, MD is the Director of the Kidney Cancer Program and the Alvin & Carrie Meinhardt Endowed Chair in Kidney Cancer Research. He Directs UCLA's Multidisciplinary VHL Program and the Society of Urologic Oncology Fellowship Program.

He completed Medical School at NYU, urology training at UCLA, and a Urologic Oncology Fellowship at the National Cancer Institute. He is an accomplished surgeon and clinical/translational researcher.

He serves in leadership positions including the NCI Renal Task Force, SWOG, the Kidney Cancer Association, and the Society of Urologic Oncology. He is recognized as an expert in kidney cancer genetic cancer syndrome and runs a translational research program with 190 peers reviewed publications in prestigious journals such as Nature, Nature Genetics, Lancet, PNAS, JCO, and CCR.

Previously Dr. Shuch was at Yale from 2013-2018 as an Associate Professor of Urology, Director of the Genitourinary Cancer Genetics and Prevention Program, and the Director Of the Genitourinary Biospecimen Repository.

Languages

English

Education

Medical Board Certification

Urology, American Board of Urology, 2015

Fellowship

Urologic:Oncology, National Cancer Institute, 2013

Residency

Urology, University of California Los Angeles, 2010

Internship

Surgery, University of California Los Angeles, 2005

Recognitions

  • ASCO Foundation Merit Award, 2013, 2012
  • UCLA Urology Guy Della Riva Award for clinical, research, and compassion, 2009
  • Longmire Surgical Society Award, 2009, 2008
  • See More

Related Clinical Trials

Locations

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Videos

Avoiding Unnecessary Treatment of the Small Renal Mass
Treatment of Large Kidney Tumors
Recurrence After Treatment – What Do I do?
What is a Renal Cyst and How Is It Treated?
What to Expect After a Robotic Partial Nephrectomy
What to Expect After a Robotic/Laparoscopic Radical Nephrectomy
Partial or Radical Nephrectomy for Larger or Invasive Tumors: One Size Doesn’t Fit All
What Are My Treatment Options for the Small Renal Mass?
Will this Tumor Grow if Left Alone?

Research

JCCC member profile

Interests

  • Sarcomatoid transformation
  • Hereditary kidney cancer
  • Precision medicine
  • Tumor heterogeneity
  • Robotic surgery
  • Adjuvant therapy
  • clinical trials

Publications

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions

  • ASCO Foundation Merit Award, 2013, 2012
  • UCLA Urology Guy Della Riva Award for clinical, research, and compassion, 2009
  • Longmire Surgical Society Award, 2009, 2008
  • ASCO Foundation Merit Award, 2009, 2008
  • Alpha Omega Alpha National Honor Society, 2004
  • Valentine Mott Award for Excellence in Urology, 2004
  • Joseph Collins Foundation Award for most outstanding graduating 4th year NYU Medical Student, 2004
  • New York University Presidential Service Award, 2001

Links